Efficacy and Outcomes of Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy Performed by Optometrists

Northeastern State University200 enrolled

Overview

The purpose of this study is to formally assess the efficacy and outcomes of optometrist-performed neodymium-doped yttrium aluminum garnet (Nd: YAG) laser capsulotomy procedures.

Participants will undergo a pre-procedure examination to establish baseline findings and to determine if they meet the inclusion criteria. Participants will undergo the Nd: YAG laser capsulotomy procedure and will be examined at 1 hour, 1 day (if necessary), 1 week, 1 month, and 3 months following the procedure. Follow-up examinations will evaluate visual acuity improvement and possible post-procedure complications. The complication rate following the laser capsulotomy procedure is typically minimal.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Posterior Capsule Opacification Obscuring Vision

Interventions

Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser CapsulotomyPROCEDURE

A Nd: YAG laser will be used to open the cloudy posterior capsule of the lens to improve central visual acuity.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Ability to provide written informed consent; 2. At least 18 years of age, male or female; 3. Prior cataract surgery; 4. Diagnosed with posterior capsule opacification obstructing vision; 5. Best-corrected visual acuity less than 20/40 or visual acuity with glare that reduces by 2 lines or more on an ETDRS visual acuity chart or significant effect on activities of daily living Exclusion Criteria: 1. History of underlying ocular disease (not including mild/moderate non-proliferative diabetic retinopathy or incidental findings) 2. Previous myopic refractive error greater than 6.00 diopters 3. Complications following previous ocular procedures (i.e. intraocular lens decentration) 4. Ocular surgery other than uncomplicated cataract or uncomplicated refractive surgery

Locations (1)

Northeastern State University

Tahlequah, Oklahoma, United States

Outcomes

Primary Outcomes

Central Visual Acuity

Pre and Post Procedure Visual Acuity

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.